News & Updates
Excerpt from the Article: A new non-invasive magnetic resonance spectroscopy technique could help providers measure how well treatments are working for patients with amyotrophic lateral sclerosis (ALS), new research has found. Specifically known as 31-phosphorus magnetic resonance spectroscopy can measure how well the mitochondria is working in patients who have this motor neuron disease (MND),…
Read More
Excerpt from the Press Release: LEXINGTON, Mass., Jan. 14, 2021 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), today announced positive interim results from the K031 non-IND controlled clinical study evaluating outpatients with mild to moderate COVID-19 disease. Patients in this non-IND clinical study were randomized within 48 hours of testing positive for COVID-19 to…
Read More
Excerpt from the Article: From cardiology to endoscopy to blood transfusion, African Americans have played an important role as innovators in the history of medicine and medtech. To help mark African American History Month, here’s a look at some of their greatest achievements. Here are 17 African American innovators who have made discoveries and invented…
Read More
Excerpt from the Article: How well a patient’s lungs recover post-COVID-19 infection is not necessarily linked with the severity of his or her disease course, but imaging shows that most patients do not experience long-term fibrosis. To date, little research has focused on lung health post-recovery, and not much is known about whether the lingering…
Read More
Excerpt from the Press Release: Phase 2 clinical trial of Brilacidin for COVID-19 anticipated to commence this month Email Print Friendly ShareJanuary 14, 2021 07:30 ET | Source: Innovation Pharmaceuticals Inc. WAKEFIELD, Mass., Jan. 14, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to announce that the…
Read More
Excerpt from the Article: Chest CT scans can provide a volumetric analysis of lung consolidation in COVID-19-positive patients, helping providers with care management and better enabling them to pinpoint which patients could die in the hospital from the virus. In a study published Jan. 6 in the European Journal of Radiology Open, investigators from Michigan…
Read More
Excerpt from the Article: Donor plasma from patients who have recovered from COVID-19 can reduce deaths in others if given early and at high enough doses, Mayo Clinic researchers found. The discovery validates one of COVID-19’s only known treatments, which will be relied on until an increase in vaccinations snuffs out the global pandemic, said…
Read More
Excerpt from the Press Release: SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (Nasdaq: ILMN) and Helix today announced a collaboration to augment national surveillance infrastructure in the US to track the emergence and prevalence of novel strains of SARS-CoV-2 with support from the CDC. The combination of Illumina’s sequencing technology and expertise and Helix’s national COVID-19 testing…
Read More
WARRINGTON, Pa., Jan. 6, 2021 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that it has dosed the first patient in its Phase 2 clinical trial studying lucinactant in acute lung injury in adults with COVID-19 associated…
Read More
Excerpt from the Press Release: PHILADELPHIA—Medications to treat high blood pressure did not affect outcomes among patients hospitalized with COVID-19, found an international team led by researchers in the Perelman School of Medicine at the University of Pennsylvania. The study, published today in The Lancet Respiratory Medicine, is the first randomized controlled trial to show…
Read MoreRequest Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?